申请人:McNaughton-Smith Andrew Grant
公开号:US20050059823A1
公开(公告)日:2005-03-17
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazolinone, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions.
提供了一种在通过调节电压依赖性钾通道的钾离子流通而对疾病进行治疗的化合物、组合物和方法。更具体地,该发明提供了喹唑啉酮、组合物和方法,可用于治疗中枢或外周神经系统疾病(如偏头痛、共济失调、帕金森病、躁郁症、三叉神经痛、痉挛、情绪障碍、脑肿瘤、精神障碍、肌肉震颤、癫痫、听力和视力丧失、阿尔茨海默病、年龄相关的记忆丧失、学习障碍、焦虑和运动神经元疾病、保持膀胱控制或治疗尿失禁)以及作为神经保护剂(例如,通过调节与所述疾况的发作或复发相关的钾通道)来预防中风等疾病。